|
NZ583931A
(en)
|
2007-08-17 |
2012-06-29 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
US9422234B2
(en)
*
|
2007-11-30 |
2016-08-23 |
The Johns Hopkins University |
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
|
|
US8855387B2
(en)
|
2007-12-28 |
2014-10-07 |
Exini Diagnostics Ab |
System for detecting bone cancer metastases
|
|
HUE034027T2
(en)
*
|
2008-08-01 |
2018-01-29 |
Univ Johns Hopkins |
Psma-binding agents and uses thereof
|
|
EP2433322A4
(en)
|
2009-05-19 |
2015-11-04 |
East Penn Mfg Co |
COMPOSITE CURRENT COLLECTOR AND RELATED METHODS
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
WO2013028664A1
(en)
|
2011-08-22 |
2013-02-28 |
Siemens Medical Solutions Usa, Inc. |
Psma imaging agents
|
|
US20130116404A1
(en)
|
2011-11-08 |
2013-05-09 |
Case Western Reserve University |
Targeted non-invasive imaging probes of egfr expressing cells
|
|
US9371360B2
(en)
|
2011-11-30 |
2016-06-21 |
The Johns Hopkins University |
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
|
|
US20140065070A1
(en)
*
|
2012-08-28 |
2014-03-06 |
Mcmaster University |
Methods of preparing triazole-containing radioiodinated compounds
|
|
KR102575825B1
(ko)
*
|
2012-11-15 |
2023-09-06 |
엔도사이트, 인코포레이티드 |
Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트
|
|
US11554183B2
(en)
*
|
2013-03-15 |
2023-01-17 |
Cancer Targeted Technology Llc |
18F-labeled PSMA-targeted PET imaging agents
|
|
US10232058B2
(en)
|
2013-10-14 |
2019-03-19 |
The Johns Hopkins University |
Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
|
|
SG11201602249RA
(en)
|
2013-10-18 |
2016-05-30 |
Deutsches Krebsforsch |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
JP6292568B2
(ja)
*
|
2013-11-06 |
2018-03-14 |
国立大学法人京都大学 |
ウレア誘導体化合物、これを含有する放射性医薬
|
|
EA035171B1
(ru)
|
2013-11-14 |
2020-05-08 |
Эндосайт, Инк. |
Конъюгаты на основе связывающихся с psma лигандов или ингибиторов psma для позитронно-эмиссионной томографии
|
|
US9713649B2
(en)
|
2014-01-24 |
2017-07-25 |
The Cleveland Clinic Foundation |
PSMA-targeting imaging agents
|
|
WO2015153772A2
(en)
|
2014-04-01 |
2015-10-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
|
|
ES2912753T3
(es)
|
2014-08-24 |
2022-05-27 |
Max Planck Gesellschaft Zur Foerderung Der Wss |
Método para la producción de ésteres activos marcados con 18F y su aplicación ejemplificada por la preparación de un marcador de PET específico de PSMA
|
|
EP2993171A1
(en)
*
|
2014-09-04 |
2016-03-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for the production of 18F-labeled PSMA-specific PET-tracers
|
|
EP3011976A1
(en)
*
|
2014-10-20 |
2016-04-27 |
Deutsches Krebsforschungszentrum |
18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents
|
|
EP3209336B1
(en)
|
2014-10-20 |
2019-12-11 |
Deutsches Krebsforschungszentrum |
18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
US10736974B2
(en)
|
2014-10-22 |
2020-08-11 |
The Johns Hopkins University |
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
WO2016112382A2
(en)
*
|
2015-01-09 |
2016-07-14 |
The Johns Hopkins University |
Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitors
|
|
US10869940B2
(en)
|
2015-06-12 |
2020-12-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Targeted photoacoustic compounds, formulations, and uses thereof
|
|
US20180236109A1
(en)
*
|
2015-08-20 |
2018-08-23 |
Universitat Zu Koln |
Pain Tracking by PET-imaging (Pain-TraP)
|
|
HRP20210183T1
(hr)
|
2015-09-30 |
2021-04-30 |
Deutsches Krebsforschungszentrum |
18f-obilježeni inhibitori specifičnog membranskog antigena prostate (psma) i njihova uporaba kao sredstava za vizualizaciju raka prostate
|
|
US20200231614A1
(en)
*
|
2015-10-22 |
2020-07-23 |
The Johns Hopkins University |
Psma targeted radiohalogenated ureas for cancer radiotherapy
|
|
KR101639599B1
(ko)
|
2015-11-09 |
2016-07-14 |
서울대학교산학협력단 |
펩타이드 싸이오우레아 유도체, 이를 포함하는 방사성 동위원소 표지 화합물 및 이를 유효 성분으로 함유하는 전립선암 치료 또는 진단용 약학적 조성물
|
|
EP3400229B1
(en)
|
2016-01-10 |
2024-03-06 |
Provincial Health Services Authority |
18/19f-labelled compounds which target the prostate specific membrane antigen
|
|
LT3481804T
(lt)
*
|
2016-06-10 |
2025-02-25 |
The Johns Hopkins University |
Radioaktyviai pažymėto prostatos specifinio membranos antigeno (psma) inhibitoriaus [18f]dcfpyl pagerinta sintezė
|
|
WO2017223357A1
(en)
*
|
2016-06-23 |
2017-12-28 |
Cornell University |
Double targeted constructs to affect tumor kill
|
|
US10806806B2
(en)
|
2016-06-23 |
2020-10-20 |
Cornell University |
Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
|
|
AU2017348111B2
(en)
|
2016-10-27 |
2023-04-06 |
Progenics Pharmaceuticals, Inc. |
Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications
|
|
JP6999960B2
(ja)
*
|
2016-11-17 |
2022-01-19 |
思路迪（北京）医薬科技有限公司 |
抗がん作用を有する化合物およびその製造方法ならびにその使用
|
|
DE102016122273B4
(de)
*
|
2016-11-18 |
2018-06-21 |
Abx Advanced Biochemical Compounds Gmbh |
Präkursoren für die Radiofluorierung
|
|
KR102724812B1
(ko)
|
2017-04-05 |
2024-11-01 |
코넬 유니버시티 |
영상화 및 항종양 치료요법에 유용한 조정 가능한 약동학을 갖는 삼작용성 작제물
|
|
JP7284707B2
(ja)
*
|
2017-04-07 |
2023-05-31 |
ジュノー セラピューティクス インコーポレイテッド |
前立腺特異的膜抗原（ｐｓｍａ）またはその改変型を発現する操作された細胞および関連方法
|
|
JP7373998B2
(ja)
|
2017-05-02 |
2023-11-06 |
コーネル・ユニバーシティー |
有効性がより大きくかつ毒性がより少ない腫瘍標的指向方法及び試薬
|
|
WO2018236115A1
(ko)
|
2017-06-19 |
2018-12-27 |
(주)퓨쳐켐 |
전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도
|
|
LT3643707T
(lt)
*
|
2017-06-19 |
2022-05-25 |
Futurechem Co., Ltd. |
18f žymėtas junginys, skirtas prostatos vėžio diagnostikai ir jo panaudojimas
|
|
EA202090776A1
(ru)
|
2017-10-23 |
2020-07-27 |
Дзе Джонс Хопкинс Юниверсити |
Визуализирующие и радиотерапевтические агенты, нацеленные на фибробласт-активирующий белок-альфа (fapalpha)
|
|
EP4008359B1
(en)
*
|
2017-12-11 |
2024-09-11 |
Technische Universität München |
Psma ligands for imaging and endoradiotherapy
|
|
US10973486B2
(en)
|
2018-01-08 |
2021-04-13 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
|
|
ES3026214T3
(en)
|
2018-01-08 |
2025-06-10 |
Progenics Pharm Inc |
System and method for rapid neural network-based image segmentation
|
|
IL276528B2
(en)
*
|
2018-02-06 |
2024-11-01 |
Univ Johns Hopkins |
PSMA Targeted Radiohalogenated Urea-Polyaminocarboxylates For Cancer Radiotherapy
|
|
WO2019183633A1
(en)
|
2018-03-23 |
2019-09-26 |
Case Western Reserve Univeristy |
Psma targeted conjugate compounds and uses thereof
|
|
BR112020020961A2
(pt)
|
2018-04-17 |
2021-01-19 |
Endocyte, Inc. |
Métodos de tratamento de câncer
|
|
CN109160896B
(zh)
*
|
2018-05-16 |
2021-06-25 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物中间体及其制备方法
|
|
CN109160899B
(zh)
*
|
2018-05-16 |
2021-06-04 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物、中间体、其制备方法及应用
|
|
CN109160898B
(zh)
*
|
2018-05-16 |
2021-06-04 |
上海如絮生物科技有限公司 |
一种亲水性吡啶类化合物中间体及其制备方法
|
|
US20210338846A1
(en)
*
|
2018-07-30 |
2021-11-04 |
The Johns Hopkins University |
Competitive prostate-specific membrane antigen (psma) binding agents for reduction of non-target organ uptake of radiolabeled psma inhibitors for psma positive tumor imaging and radiopharmaceutical therapy
|
|
CA3115806A1
(en)
|
2018-10-11 |
2020-04-16 |
Progenics Pharmaceuticals, Inc |
Combination therapy for treating metastatic prostate cancer
|
|
RU2697519C1
(ru)
*
|
2018-10-15 |
2019-08-15 |
Общество с ограниченной ответственностью "Изварино Фарма" |
Средство пептидной природы, включающее псма-связывающий лиганд на основе производного мочевины, способ его получения и применение для получения конъюгата с лекарственным и диагностическим агентом
|
|
KR102403970B1
(ko)
|
2018-12-27 |
2022-05-31 |
(주)퓨쳐켐 |
카르복시산이 도입된 psma-표적 화합물 및 그의 용도
|
|
US11657508B2
(en)
|
2019-01-07 |
2023-05-23 |
Exini Diagnostics Ab |
Systems and methods for platform agnostic whole body image segmentation
|
|
PL239934B1
(pl)
*
|
2019-04-12 |
2022-01-31 |
Narodowe Centrum Badan Jadrowych Osrodek Radioizotopow Polatom |
Pochodne inhibitorów PSMA do znakowania ⁹⁹ᵐTc poprzez HYNIC, zestaw radiofarmaceutyczny, preparat radiofarmaceutyczny oraz ich zastosowanie w diagnostyce raka prostaty
|
|
CA3136979A1
(en)
|
2019-04-17 |
2020-10-22 |
Provincial Health Services Authority |
Radiolabelled compounds for diagnosis or treatment of prostate-spe cific membrane antigen-expressing cancer
|
|
US11948283B2
(en)
|
2019-04-24 |
2024-04-02 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for interactive adjustment of intensity windowing in nuclear medicine images
|
|
TWI872062B
(zh)
|
2019-04-24 |
2025-02-11 |
美商普吉尼製藥公司 |
用於偵測轉移之骨掃描影像之自動及互動式分析系統、裝置及方法
|
|
CN120097929A
(zh)
|
2019-05-20 |
2025-06-06 |
因多塞特股份有限公司 |
制备psma缀合物的方法
|
|
CN119431260A
(zh)
|
2019-06-21 |
2025-02-14 |
省卫生服务机构 |
靶向前列腺特异性膜抗原的放射性标记化合物
|
|
RU2713151C1
(ru)
*
|
2019-07-02 |
2020-02-04 |
Общество с ограниченной ответственностью "Изварино Фарма" |
Конъюгат флуоресцентного красителя с веществом пептидной природы, включающим псма-связывающий лиганд на основе производного мочевины для визуализации клеток, экспрессирующих псма, способ его получения и применения
|
|
CA3149598A1
(en)
*
|
2019-08-30 |
2021-03-04 |
Naga Vara Kishore PILLARSETTY |
Novel theranostic agents for psma positive cancers
|
|
US11564621B2
(en)
|
2019-09-27 |
2023-01-31 |
Progenies Pharmacenticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US11544407B1
(en)
|
2019-09-27 |
2023-01-03 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for secure cloud-based medical image upload and processing
|
|
US11900597B2
(en)
|
2019-09-27 |
2024-02-13 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
US12417533B2
(en)
|
2019-09-27 |
2025-09-16 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for artificial intelligence-based image analysis for cancer assessment
|
|
KR102269315B1
(ko)
|
2019-10-24 |
2021-06-24 |
서울대학교산학협력단 |
전립선 암의 영상 또는 치료를 위한 동위원소 표지 화합물
|
|
US11321844B2
(en)
|
2020-04-23 |
2022-05-03 |
Exini Diagnostics Ab |
Systems and methods for deep-learning-based segmentation of composite images
|
|
US11386988B2
(en)
|
2020-04-23 |
2022-07-12 |
Exini Diagnostics Ab |
Systems and methods for deep-learning-based segmentation of composite images
|
|
CN111548305B
(zh)
*
|
2020-05-12 |
2021-08-31 |
北京师范大学 |
一种可用于靶向psma的喹啉类化合物及其制备方法
|
|
US11721428B2
(en)
|
2020-07-06 |
2023-08-08 |
Exini Diagnostics Ab |
Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions
|
|
WO2022008374A1
(en)
|
2020-07-06 |
2022-01-13 |
Exini Diagnostics Ab |
Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesions
|
|
EP4244216A1
(en)
|
2020-11-12 |
2023-09-20 |
ABX Advanced Biochemical Compounds GmbH |
Ligands of prostate specific membrane antigen (psma) containing heteroaromatic linker building blocks
|
|
CN114685599A
(zh)
*
|
2020-12-30 |
2022-07-01 |
南京江原安迪科正电子研究发展有限公司 |
一种psma靶向抑制剂及放射性核素标记的psma靶向抑制剂、制备方法和用途
|
|
KR20240072996A
(ko)
|
2021-07-30 |
2024-05-24 |
오사카 유니버시티 |
방사성 표지된 화합물 및 이의 용도
|
|
US20230115732A1
(en)
|
2021-10-08 |
2023-04-13 |
Exini Diagnostics Ab |
Systems and methods for automated identification and classification of lesions in local lymph and distant metastases
|
|
EP4429654A4
(en)
|
2021-11-09 |
2025-07-09 |
Univ Case Western Reserve |
PSMA-TARGETED CONJUGATE COMPOUNDS AND THEIR USES
|
|
CN119325617A
(zh)
|
2022-06-08 |
2025-01-17 |
普罗热尼奇制药公司 |
评估疾病负荷和进展的系统和方法
|
|
EP4648799A1
(en)
|
2023-01-10 |
2025-11-19 |
Sun Pharma Advanced Research Company Ltd |
Ligand-drug conjugates
|
|
US20240285248A1
(en)
|
2023-02-13 |
2024-08-29 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for predicting biochemical progression free survival in prostate cancer patients
|
|
CN116217505B
(zh)
*
|
2023-03-17 |
2024-10-01 |
南京医科大学 |
用于诊断或治疗表达前列腺特异性膜抗原癌症的新型标记靶向剂
|
|
WO2024211651A1
(en)
|
2023-04-07 |
2024-10-10 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for facilitating lesion inspection and analysis
|
|
WO2025072177A1
(en)
|
2023-09-25 |
2025-04-03 |
Progenics Pharmaceuticals, Inc. |
Systems and methods for automated cancer staging and risk prediction
|
|
WO2025090594A1
(en)
*
|
2023-10-25 |
2025-05-01 |
The Johns Hopkins University |
Deep transfer learning for fully automated tumor quantification and prognosis of cancer on pet/ct
|
|
DE102023133281B8
(de)
*
|
2023-11-28 |
2025-07-24 |
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien Gmbh |
Radiotracer und Präkursoren für diese Radiotracer sowie Verwendung dieser Radiotracer als Diagnostika und Therapeutika
|
|
CN117670883B
(zh)
*
|
2024-01-31 |
2024-05-07 |
中国医学科学院北京协和医院 |
一种鉴别高低级别膀胱癌的方法、设备和系统
|